NDC 55111-497

capecitabine

Capecitabine

capecitabine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Dr. Reddy's Laboratories Limited. The primary component is Capecitabine.

Product ID55111-497_3bc9e05b-5035-24e6-a730-989e8e0b29ae
NDC55111-497
Product TypeHuman Prescription Drug
Proprietary Namecapecitabine
Generic NameCapecitabine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-12-10
Marketing CategoryANDA / ANDA
Application NumberANDA204345
Labeler NameDr. Reddy's Laboratories Limited
Substance NameCAPECITABINE
Active Ingredient Strength500 mg/1
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 55111-497-04

120 TABLET in 1 BOTTLE (55111-497-04)
Marketing Start Date2020-12-10
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "capecitabine" or generic name "Capecitabine"

NDCBrand NameGeneric Name
0054-0271CapecitabineCapecitabine
0054-0272CapecitabineCapecitabine
0093-7473CapecitabineCapecitabine
0093-7474CapecitabineCapecitabine
0378-2511Capecitabinecapecitabine
0378-2512Capecitabinecapecitabine
16714-467CAPECITABINECAPECITABINE
67877-458CapecitabineCapecitabine
67877-459CapecitabineCapecitabine
69097-949CapecitabineCapecitabine
69097-948CapecitabineCapecitabine
69539-019CapecitabineCapecitabine
69539-020CapecitabineCapecitabine
72205-006CapecitabineCapecitabine
72205-007CapecitabineCapecitabine
16714-468CAPECITABINECAPECITABINE
16729-072CAPECITABINECAPECITABINE
16729-073CAPECITABINECAPECITABINE
42291-167CapecitabineCapecitabine
50268-154CapecitabineCapecitabine
51079-510CapecitabineCapecitabine
51407-095CapecitabineCapecitabine
51407-096CapecitabineCapecitabine
59651-204CapecitabineCapecitabine
59651-205CapecitabineCapecitabine
60687-149CapecitabineCapecitabine
63759-3000CapecitabineCapecitabine
63759-3001CapecitabineCapecitabine
64980-277CapecitabineCapecitabine
64980-276CapecitabineCapecitabine
65162-844CapecitabineCapecitabine
65162-843CapecitabineCapecitabine
0004-1100Xelodacapecitabine
0004-1101Xelodacapecitabine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.